z-logo
open-access-imgOpen Access
Non‐lymphoid and lymphoid cells in acute, chronic and relapsing experimental colitis
Author(s) -
PALMEN M. J. H. J.,
DIELEMAN L. A.,
ENDE M. B.,
UYTERLINDE A.,
PEÑA A. S.,
MEUWISSEN S. G. M.,
REES E. P.
Publication year - 1995
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/j.1365-2249.1995.tb05537.x
Subject(s) - immunology , lymphatic system , colitis , medicine , innate lymphoid cell , immunity , immune system
SUMMARY In rodents, intracolonic administration of ethanol 30% induces an acute colitis, while administration of 2,4,6‐trinitrobenzene sulphonic acid (TNBS) in ethanol induces a longer lasting colitis. In the acute and chronic stages of experimental colitis, lymphoid and non‐lymphoid cells were studied in the colon by immunohistochemistry. During the acute inflammation a high damage score of the colon was observed, which was related to an increase in the number of macrophages and granulocytes. Also a change in distributional patterns of macrophage subpopulations was found. The chronic stage of TNBS–ethanol‐induced colitis was characterized by an increase in the number of lymphocytes, especially T cells. These data suggest that macrophages and granulocytes are important in the acute phase of experimental colitis, while lymphocytes play a pivotal role in the chronic stage. As most inflammatory bowel disease (IBD) patients have relapses during the chronic disease, we attempted to induce a relapse during experimental colitis by giving a second i.p. or s.c. dose of TNBS. This resulted in increased damage scores of the colon, new areas of ulceration and a further increase in macrophage numbers. No effect on the number of granulocytes was seen. These results indicate that it is possible to mimic relapses in experimental colitis by a second administration of TNBS, and suggest that the rats had been sensitized by the first dose of TNBS, given into the colon.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here